Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Mitsuo Iwadate"'
Autor:
Akihiro Tamori, Masaru Enomoto, Michiyo Hayakawa, Takashi Honda, Mitsuo Iwadate, Saori Itami-Matsumoto, Yoshihiko Yano, Hideaki Umeyama, Yoshiki Murakami, Ritsuzo Kozuka, Y-h. Taguchi, Norifumi Kawada
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Autor:
Ritsuzo Kozuka, Akihiro Tamori, Saori Itami-Matsumoto, Mitsuo Iwadate, Takashi Honda, Hideaki Umeyama, Masaru Enomoto, Y-h. Taguchi, Norifumi Kawada, Yoshihiko Yano, Yoshiki Murakami, Michiyo Hayakawa
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
Nucleos(t)ide analog (NA) therapy has proven effective in treating chronic hepatitis B. However, NAs frequently result in viral relapse after the cessation of therapy. This is because NAs cannot fully eliminate the viral episomal covalently closed ci
Publikováno v:
BMC Medical Genomics. 8/12/2016, Vol. 9, p69-79. 11p.
Autor:
Makiko, Kosugi, Shin-ichiro, Ozawa, Rika, Okamoto, Yurie, Kubo, Mitsuo, Iwadate, Yasuhiro, Kamei, Sakae, Kudoh, Yasuhiro, Kashino, Yuichiro, Takahashi, Shigeru, Itoh, Kojiro, Hara, Hiroyuki, Koike
The Ninth Symposium on Polar Science/Ordinary sessions: [OB] Polar biology, Wed. 5 Dec. / Entrance Hall (1st floor), National Institute of Polar Research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::c62b3523314e674d0cf0ad9fca7454ea
http://id.nii.ac.jp/1291/00015238/
http://id.nii.ac.jp/1291/00015238/
Autor:
Hideaki Umeyama, Go Watanabe, Shunsuke Sato, Shigetaka Yoneda, Yoshiki Murakami, Michiyo Hayakawa, Mitsuo Iwadate
Publikováno v:
CHEMICAL & PHARMACEUTICAL BULLETIN. 64:1393-1396
Hepatitis B virus (HBV) chronically infects millions of people worldwide and is a major cause of serious liver diseases, including liver cirrhosis and liver cancer. In our previous study, in silico screening was used to isolate new anti-viral compoun
Publikováno v:
BMC Bioinformatics. 2015, Vol. 16 Issue 1, p1-26. 26p. 4 Diagrams, 9 Charts, 12 Graphs.
Autor:
Hideaki Umeyama1 (AUTHOR), Mitsuo Iwadate1 (AUTHOR), Taguchi, Y-h.2 (AUTHOR) tag@granular.com
Publikováno v:
BMC Genomics. 2014 Suppl 9, Vol. 15, p1-12. 12p. 3 Charts, 4 Graphs.
Autor:
Daisuke Kobayashi, Attayeb Mohsen, Masakazu Sekijima, Tomoki Ito, M. Michael Gromiha, Masahiro Mochizuki, Mika Sakamoto, Kenji Mizuguchi, Modong Tan, Hideaki Umeyama, Nobuaki Yasuo, Shuntaro Chiba, Shogo Suzuki, Takashi Ishida, Kazuyoshi Ikeda, Daisuke Kihara, Yoshitaka Moriwaki, Yutaka Akiyama, Reiji Teramoto, A. Mary Thangakani, Shintaro Minami, Vipul Gupta, Mitsuo Iwadate, Chioko Nagao, Takaaki Ichikawa, Kazuki Yamamoto, Masahito Ohue, Itsuo Nakane, Kei Yura, Tatsuya Okuno, George Chikenji, Masahiro Kawatani, Kun Yi Hsin, Sakurako Takashina, Takatsugu Hirokawa, Woong-Hee Shin, Devadasan Velmurugan, Hayase Hakariya, Chandrasekaran Ramakrishnan, Ryunosuke Yoshino, Hironori K. Nakamura, Philip Prathipati, Nobuaki Miura, Hiroaki Kitano, Sergey Zozulya, Mari Ito, Akiko Higuchi, Teruki Honma, Petro Borysko, Keita Oda, Anastasiia Gryniukova, Nanako Uchida, Kentaroh Kudoh
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Potential inhibitors of a target biomolecule, NAD-dependent deacetylase Sirtuin 1, were identified by a contest-based approach, in which participants were asked to propose a prioritized list of 400 compounds from a designated compound library contain
Publikováno v:
IPSJ Transactions on Bioinformatics. 8:14-20
Background: Spleen tyrosine kinase (SYK) is a protein related to various diseases. Aberrant SYK expression often causes the progression and initiation of several diseases including cancer and autoimmune diseases. Despite the importance of inhibiting
Autor:
Ryoichi Kinoshita1 (AUTHOR), Mitsuo Iwadate2 (AUTHOR), Hideaki Umeyama2 (AUTHOR), Y-h Taguchi1 (AUTHOR) tag@granular.com
Publikováno v:
BMC Systems Biology. 2014 Suppl 1, Vol. 8, p1-17. 17p. 2 Diagrams, 7 Charts, 7 Graphs.